BioPharma Dive November 8, 2024
Amy Baxter

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate if given a role in the incoming Trump administration.

With the U.S. presidential election decided, one name is suddenly circulating in healthcare: Robert F. Kennedy Jr.

President-elect Donald Trump has promised Kennedy a large role in his new administration, signaling he could be handed influence guiding some of the nation’s health policies. And Kennedy, who does not have medical or public health degrees, has made it clear he has big ideas for change.

This week, Kennedy outlined three goals directed to him from Trump: “clean up corruption,” return health agencies to evidence-based science and “make america healthy again.” He didn’t present evidence of corruption, nor acknowledge...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Washington Power Has Shifted. Here's How the ACA May Shift, Too.
Hospital recovery at risk if Congress doesn’t extend telehealth, Fitch Ratings says
Podcast: What Direction Will Alternative Payment Models Head Over the Next Four Years? 11/21/24
Trump Is Back: What This Could Mean for Health Policy
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article